Literature DB >> 30776097

GM1 promotes TrkA-mediated neuroblastoma cell differentiation by occupying a plasma membrane domain different from TrkA.

Elena Chiricozzi1, Erika Di Biase1, Margherita Maggioni1, Giulia Lunghi1, Maria Fazzari1, Diego Yuri Pomè1, Riccardo Casellato1, Nicoletta Loberto1, Laura Mauri1, Sandro Sonnino1.   

Abstract

Recently, we highlighted that the ganglioside GM1 promotes neuroblastoma cells differentiation by activating the TrkA receptor through the formation of a TrkA-GM1 oligosaccharide complex at the cell surface. To study the TrkA-GM1 interaction, we synthesized two radioactive GM1 derivatives presenting a photoactivable nitrophenylazide group at the end of lipid moiety, 1 or at position 6 of external galactose, 2; and a radioactive oligosaccharide portion of GM1 carrying the nitrophenylazide group at position 1 of glucose, 3. The three compounds were singly administered to cultured neuroblastoma Neuro2a cells under established conditions that allow cell surface interactions. After UV activation of photoactivable compounds, the proteins were analyzed by PAGE separation. The formation of cross-linked TrkA-GM1 derivatives complexes was identified by both radioimaging and immunoblotting. Results indicated that the administration of compounds 2 and 3, carrying the photoactivable group on the oligosaccharide, led to the formation of a radioactive TrkA complex, while the administration of compound 1 did not. This underlines that the TrkA-GM1 interaction directly involves the GM1 oligosaccharide, but not the ceramide. To better understand how GM1 relates to the TrkA, we isolated plasma membrane lipid rafts. As expected, GM1 was found in the rigid detergent-resistant fractions, while TrkA was found as a detergent soluble fraction component. These results suggest that TrkA and GM1 belong to separate membrane domains: probably TrkA interacts by 'flopping' down its extracellular portion onto the membrane, approaching its interplay site to the oligosaccharide portion of GM1.
© 2019 International Society for Neurochemistry.

Entities:  

Keywords:  GM1; GM1 oligosaccharide; TrkA; lipid rafts; neurodifferentiation

Mesh:

Substances:

Year:  2019        PMID: 30776097     DOI: 10.1111/jnc.14685

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

1.  TTF1 suppresses neuroblastoma growth and induces neuroblastoma differentiation by targeting TrkA and the miR-204/TrkB axis.

Authors:  Tianyou Yang; Jiahao Li; Zhenjian Zhuo; Huijuan Zeng; Tianbao Tan; Lei Miao; Manna Zheng; Jiliang Yang; Jing Pan; Chao Hu; Yan Zou; Jing He; Huimin Xia
Journal:  iScience       Date:  2022-06-23

Review 2.  Gangliosides in nervous system development, regeneration, and pathologies.

Authors:  Juliana F Vasques; Renata Guedes de Jesus Gonçalves; Almir Jordão da Silva-Junior; Robertta Silva Martins; Fernanda Gubert; Rosalia Mendez-Otero
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

3.  Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System.

Authors:  Massimo Aureli; Laura Mauri; Emma Veronica Carsana; Dorina Dobi; Silvia Breviario; Giulia Lunghi; Sandro Sonnino
Journal:  Adv Neurobiol       Date:  2023

4.  GM1 Oligosaccharide Crosses the Human Blood-Brain Barrier In Vitro by a Paracellular Route.

Authors:  Erika Di Biase; Giulia Lunghi; Margherita Maggioni; Maria Fazzari; Diego Yuri Pomè; Nicoletta Loberto; Maria Grazia Ciampa; Pamela Fato; Laura Mauri; Emmanuel Sevin; Fabien Gosselet; Sandro Sonnino; Elena Chiricozzi
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

5.  GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease.

Authors:  Giulia Mancini; Nicoletta Loberto; Debora Olioso; Maria Cristina Dechecchi; Giulio Cabrini; Laura Mauri; Rosaria Bassi; Domitilla Schiumarini; Elena Chiricozzi; Giuseppe Lippi; Emanuela Pesce; Sandro Sonnino; Nicoletta Pedemonte; Anna Tamanini; Massimo Aureli
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

Review 6.  GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration.

Authors:  Elena Chiricozzi; Giulia Lunghi; Erika Di Biase; Maria Fazzari; Sandro Sonnino; Laura Mauri
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

7.  Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1+/- mouse model.

Authors:  Elena Chiricozzi; Laura Mauri; Giulia Lunghi; Erika Di Biase; Maria Fazzari; Margherita Maggioni; Manuela Valsecchi; Simona Prioni; Nicoletta Loberto; Diego Yuri Pomè; Maria Grazia Ciampa; Pamela Fato; Gianluca Verlengia; Stefano Cattaneo; Robert Assini; Gusheng Wu; Samar Alselehdar; Robert W Ledeen; Sandro Sonnino
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

Review 8.  Gangliosides as Signaling Regulators in Cancer.

Authors:  Norihiko Sasaki; Masashi Toyoda; Toshiyuki Ishiwata
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

9.  Neurotrophic effects of GM1 ganglioside, NGF, and FGF2 on canine dorsal root ganglia neurons in vitro.

Authors:  S Schwarz; A Lehmbecker; W Tongtako; K Hahn; Y Wang; F Felmy; I Zdora; G Brogden; K Branitzki-Heinemann; M von Köckritz-Blickwede; W Baumgärtner; I Gerhauser
Journal:  Sci Rep       Date:  2020-03-25       Impact factor: 4.379

10.  Modulation of calcium signaling depends on the oligosaccharide of GM1 in Neuro2a mouse neuroblastoma cells.

Authors:  Giulia Lunghi; Maria Fazzari; Erika Di Biase; Laura Mauri; Sandro Sonnino; Elena Chiricozzi
Journal:  Glycoconj J       Date:  2020-11-17       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.